{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:32:56Z","timestamp":1791894776851,"version":"4.3.4"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2024YFD1800505"],"award-info":[{"award-number":["2024YFD1800505"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFD1800800"],"award-info":[{"award-number":["2022YFD1800800"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.vaccine.2025.127572","type":"journal-article","created":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T01:07:20Z","timestamp":1754356040000},"page":"127572","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["PRRSV vector vaccine based on VEEV-VSVG recombinant replicon elicits efficient immune responses in piglets"],"prefix":"10.1016","volume":"62","author":[{"given":"Zhenxiang","family":"Rong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingjin","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linxing","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingran","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengxin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shudan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liuqing","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huanchun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangmin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2025.127572_bb0005","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1099\/vir.0.056341-0","article-title":"Arterivirus molecular biology and pathogenesis","volume":"94","author":"Snijder","year":"2013","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2025.127572_bb0010","doi-asserted-by":"crossref","first-page":"E2920","DOI":"10.1073\/pnas.1211145109","article-title":"Efficient-2 frameshifting by mammalian ribosomes to synthesize an additional arterivirus protein","volume":"109","author":"Fang","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.vaccine.2025.127572_bb0015","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1006\/viro.1996.0356","article-title":"Intracellular synthesis, processing, and transport of proteins encoded by ORFs 5 to 7 of porcine reproductive and respiratory syndrome virus","volume":"221","author":"Helmi","year":"1996","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2025.127572_bb0020","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1128\/JVI.01774-09","article-title":"The minor envelope glycoproteins GP2a and GP4 of porcine reproductive and respiratory syndrome virus interact with the receptor CD163","volume":"84","author":"Das","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.vaccine.2025.127572_bb0025","doi-asserted-by":"crossref","first-page":"3994","DOI":"10.1128\/JVI.80.8.3994-4004.2006","article-title":"Influence of N-linked glycosylation of porcine reproductive and respiratory syndrome virus GP5 on virus infectivity, antigenicity, and ability to induce neutralizing antibodies","volume":"80","author":"Ansari","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.vaccine.2025.127572_bb0030","first-page":"12","article-title":"Immunological evaluation of recombination PRRSV GP3 and GP5 DNA vaccines in vivo","author":"Zhao","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.vaccine.2025.127572_bb0035","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1016\/j.vaccine.2015.06.020","article-title":"A novel DNA vaccine for reduction of PRRSV-induced negative immunomodulatory effects: a proof of concept","volume":"33","author":"Suradhat","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.127572_bb0040","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.vetimm.2016.11.002","article-title":"Positive immunomodulatory effects of heterologous DNA vaccine- modified live vaccine, prime-boost immunization, against the highly-pathogenic PRRSV infection","volume":"183","author":"Sirisereewan","year":"2017","journal-title":"Vet. Immunol. Immunopathol."},{"key":"10.1016\/j.vaccine.2025.127572_bb0045","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1089\/hum.2013.009","article-title":"Vesicular stomatitis virus glycoprotein\u2013 and venezuelan equine encephalitis virus-derived glycoprotein\u2013pseudotyped lentivirus vectors differentially transduce corneal endothelium, trabecular meshwork, and human photoreceptors","volume":"25","author":"Lipinski","year":"2014","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.vaccine.2025.127572_bb0050","first-page":"6","article-title":"Intranasal delivery of replicating mRNA encoding neutralizing antibody against SARS-CoV-2 infection in mice","author":"Li","year":"2021","journal-title":"Signal transduction and targeted therapy"},{"key":"10.1016\/j.vaccine.2025.127572_bb0055","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/s41417-022-00435-8","article-title":"Next generation self-replicating RNA vectors for vaccines and immunotherapies","volume":"30","author":"Aliahmad","year":"2022","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.vaccine.2025.127572_bb0060","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.3390\/v15112247","article-title":"Pathogenicity studies of NADC34-like porcine reproductive and respiratory syndrome virus LNSY-GY and NADC30-like porcine reproductive and respiratory syndrome virus GXGG-8011 in piglets","volume":"15","author":"Zhu","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.vaccine.2025.127572_bb0065","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1128\/mr.58.3.491-562.1994","article-title":"The alphaviruses gene expression, replication, and evolution","volume":"58","author":"Strauss","year":"1994","journal-title":"Microbiol. Rev."},{"key":"10.1016\/j.vaccine.2025.127572_bb0070","first-page":"447","article-title":"Alphavirus vectors for vaccine production and gene therapy","volume":"2","author":"Lundstrom","year":"2003","journal-title":"Vaccines"},{"key":"10.1016\/j.vaccine.2025.127572_bb0075","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1089\/aid.1998.14.1369","article-title":"Comparative analysis of humoral immune responses to HIV type 1 envelope glycoproteins in mice immunized with a DNA vaccine, recombinant Semliki Forest virus RNA, or recombinant Semliki Forest virus particles","volume":"14","author":"Brand","year":"1998","journal-title":"AIDS Res. Hum. Retrovir."},{"key":"10.1016\/j.vaccine.2025.127572_bb0080","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0166-0934(99)00009-9","article-title":"Generation of monoclonal antibodies to native human immunodeficiency virus type 1 envelope glycoprotein by immunization of mice with naked RNA","volume":"79","author":"Giraud","year":"1999","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.vaccine.2025.127572_bb0085","doi-asserted-by":"crossref","first-page":"3031","DOI":"10.1128\/jvi.71.4.3031-3038.1997","article-title":"Humoral, mucosal, and cellular immunity in response to a human immunodeficiency virus type 1 immunogen expressed by a Venezuelan equine encephalitis virus vaccine vector","volume":"71","author":"Caley","year":"1997","journal-title":"J. Virol."},{"key":"10.1016\/j.vaccine.2025.127572_bb0090","doi-asserted-by":"crossref","first-page":"6527","DOI":"10.1128\/JVI.72.8.6527-6536.1998","article-title":"Identification of a human immunodeficiency virus type 2 (HIV-2) encapsidation determinant and transduction of nondividing human cells by HIV-2-based lentivirus vectors","volume":"72","author":"Poeschla","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.vaccine.2025.127572_bb0095","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1089\/10430340050129486","article-title":"Development of novel simian immunodeficiency virus vectors carrying a dual gene expression system","volume":"11","author":"Nakajima","year":"2000","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.vaccine.2025.127572_bb0100","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1038\/sj.gt.3301292","article-title":"Characterization of novel safe lentiviral vectors derived from simian immunodeficiency virus (SIVmac251) that efficiently transduce mature human dendritic cells","volume":"7","author":"N\u00e8gre","year":"2000","journal-title":"Gene Ther."},{"key":"10.1016\/j.vaccine.2025.127572_bb0105","doi-asserted-by":"crossref","first-page":"16866","DOI":"10.1073\/pnas.1414991111","article-title":"In vitro evolution of high-titer, virus-like vesicles containing a single structural protein","volume":"111","author":"Rose","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.vaccine.2025.127572_bb0110","doi-asserted-by":"crossref","first-page":"10708","DOI":"10.1073\/pnas.1408677111","article-title":"Enhancement of protein expression by alphavirus replicons by designing self-replicating subgenomic RNAs","volume":"111","author":"Kim","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.vaccine.2025.127572_bb0115","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.vetmic.2017.04.016","article-title":"GP5 of porcine reproductive and respiratory syndrome virus (PRRSV) as a target for homologous and broadly neutralizing antibodies","volume":"209","author":"Popescu","year":"2017","journal-title":"Vet. Microbiol."},{"key":"10.1016\/j.vaccine.2025.127572_bb0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0065548","article-title":"Signal peptide cleavage from GP5 of PRRSV: a minor fraction of molecules retains the decoy epitope, a presumed molecular cause for viral persistence","volume":"8","author":"Thaa","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2025.127572_bb0125","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.vaccine.2010.11.046","article-title":"Construction and immunogenicity of DNA vaccines encoding fusion protein of murine complement C3d-p28 and GP5 gene of porcine reproductive and respiratory syndrome virus","volume":"29","author":"Zhang","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.127572_bb0130","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.virusres.2015.11.005","article-title":"Evaluation of the use of non-pathogenic porcine circovirus type 1 as a vaccine delivery virus vector to express antigenic epitopes of porcine reproductive and respiratory syndrome virus","volume":"213","author":"Pi\u00f1eyro","year":"2016","journal-title":"Virus Res."},{"key":"10.1016\/j.vaccine.2025.127572_bb0135","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.virusres.2010.08.026","article-title":"GP4-specific neutralizing antibodies might be a driving force in PRRSV evolution","volume":"154","author":"Costers","year":"2010","journal-title":"Virus Res."},{"key":"10.1016\/j.vaccine.2025.127572_bb0140","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1292\/jvms.19-0283","article-title":"Construction and immunological evaluation of recombinant adenovirus vaccines co-expressing GP3 and GP5 of EU-type porcine reproductive and respiratory syndrome virus in pigs","volume":"81","author":"Xie","year":"2019","journal-title":"J. Vet. Med. Sci."},{"key":"10.1016\/j.vaccine.2025.127572_bb0145","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.vaccine.2006.07.032","article-title":"Immunogenicity and protective efficacy of recombinant pseudorabies virus expressing the two major membrane-associated proteins of porcine reproductive and respiratory syndrome virus","volume":"25","author":"Jiang","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.127572_bb0150","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.jconrel.2021.09.008","article-title":"Polyplex nanomicelle delivery of self-amplifying RNA vaccine","volume":"338","author":"Chang","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.vaccine.2025.127572_bb0155","first-page":"28","article-title":"Epitope screening and vaccine molecule design of PRRSV GP3 and GP5 protein based on immunoinformatics","author":"Liu","year":"2024","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.vaccine.2025.127572_bb0160","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1089\/jir.2017.0101","article-title":"IL-2 and beyond in Cancer immunotherapy","volume":"38","author":"Wrangle","year":"2018","journal-title":"J. Interf. Cytokine Res."},{"key":"10.1016\/j.vaccine.2025.127572_bb0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/jop.12142","article-title":"Inflammation-related cytokines in oral lichen planus: an overview","volume":"44","author":"Lu","year":"2013","journal-title":"J. Oral Pathol. Med."},{"key":"10.1016\/j.vaccine.2025.127572_bb0170","article-title":"Highly efficient expression of Interleukin-2 under the control of rabbit \u03b2-globin intron II gene enhances protective immune responses of porcine reproductive and respiratory syndrome (PRRS) DNA vaccine in pigs","volume":"9","author":"Du","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2025.127572_bb0175","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1089\/vim.2009.0003","article-title":"Changes in lymphocyte subsets and cytokines during European porcine reproductive and respiratory syndrome increased expression of IL-12 and IL-10 and proliferation of CD4(\u2212)CD8(high)","volume":"22","author":"G\u00f3mez-Laguna","year":"2009","journal-title":"Viral Immunol."},{"key":"10.1016\/j.vaccine.2025.127572_bb0180","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/path.2287","article-title":"TNF-mediated inflammatory disease","volume":"214","author":"Bradley","year":"2007","journal-title":"J. Pathol."},{"key":"10.1016\/j.vaccine.2025.127572_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.vetmic.2022.109513","article-title":"IL-1\u03b2 induced by PRRSV co-infection inhibited CSFV C-strain proliferation via the TLR4\/NF-\u03baB\/MAPK pathways and the NLRP3 inflammasome","volume":"273","author":"Chen","year":"2022","journal-title":"Vet. Microbiol."},{"key":"10.1016\/j.vaccine.2025.127572_bb0190","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jcpa.2009.07.004","article-title":"Cytokine expression by macrophages in the lung of pigs infected with the porcine reproductive and respiratory syndrome virus","volume":"142","author":"G\u00f3mez-Laguna","year":"2010","journal-title":"J. Comp. Pathol."},{"key":"10.1016\/j.vaccine.2025.127572_bb0195","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.vetimm.2010.01.002","article-title":"Expression of inflammatory cytokines and toll-like receptors in the brain and respiratory tract of pigs infected with porcine reproductive and respiratory syndrome virus","volume":"135","author":"Miguel","year":"2010","journal-title":"Vet. Immunol. Immunopathol."},{"key":"10.1016\/j.vaccine.2025.127572_bb0200","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.virol.2013.08.008","article-title":"Chinese and Vietnamese strains of HP-PRRSV cause different pathogenic outcomes in United States high health swine","volume":"446","author":"Guo","year":"2013","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2025.127572_bb0205","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.virol.2012.09.013","article-title":"Experimental infection of United States swine with a Chinese highly pathogenic strain of porcine reproductive and respiratory syndrome virus","volume":"435","author":"Guo","year":"2013","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2025.127572_bb0210","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.4049\/jimmunol.172.3.1916","article-title":"Lymphoid hyperplasia resulting in immune dysregulation is caused by porcine reproductive and respiratory syndrome virus infection in neonatal pigs","volume":"172","author":"Lemke","year":"2004","journal-title":"J. Immunol."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25008692?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25008692?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T03:26:28Z","timestamp":1766546788000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X25008692"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":42,"alternative-id":["S0264410X25008692"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.127572","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PRRSV vector vaccine based on VEEV-VSVG recombinant replicon elicits efficient immune responses in piglets","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.127572","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"127572"}}